MorphoSys AG buy exploration
Summary
This prediction ended on 03.08.18 with a price of €104.40. The prediction had a final performance of 13.85%. exploration has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG | 0.295% | 0.295% | 185.295% | -5.364% |
| iShares Core DAX® | -0.552% | 3.405% | 17.621% | 18.214% |
| iShares Nasdaq 100 | -1.415% | 4.613% | 28.506% | 54.410% |
| iShares Nikkei 225® | -0.877% | -1.396% | 9.284% | 4.292% |
| iShares S&P 500 | -0.415% | 3.338% | 25.914% | 47.401% |
Comments by exploration for this prediction
In the thread Morphosys AG diskutieren
Morphosys: nicht dynamisch aber stetig nach oben
- nicht dynamisch aber stetig geht es nach oben.
- keine Wiederstände nach oben
- letzte ATH November 2014 bei 88,50€. Da sind wir drüber und sollte nun als Unterstützung dienen. Bis dahin würde ich auch nachkaufen. (Abstauberlimit).
- unter 88,50 kann es wieder bis auf 71€ gehen. Mein SL liegt bei ca. 87€